Physician profile
Ikemefula Ekekwe
NPI 1952505570
$4,319.44
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $141 · 2021: $413 · 2022: $1,746 · 2023: $1,324 · 2024: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,459 · Travel and Lodging: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,458.65 |
| Travel and Lodging | $295.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,265.96 | 2019-2024 | Nucala, Trelegy Ellipta, Arexvy |
| Inspire Medical Systems, INC. | $1,258.71 | 2022-2024 | Inspire |
| Astrazeneca Pharmaceuticals Lp | $436.48 | 2021-2024 | Tezspire, Airsupra, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $307.44 | 2019-2023 | Stiolto Respimat |
| Genzyme Corporation | $191.99 | 2019-2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $158.90 | 2021-2024 | Glassia |
| Axsome Therapeutics, INC. | $108.28 | 2023 | Sunosi |
| Mylan Specialty L.P. | $89.32 | 2019-2023 | Yupelri |
| Jazz Pharmaceuticals INC. | $73.55 | 2019-2022 | |
| Amgen INC. | $69.08 | 2023-2024 | Tezspire |
| Advanced Respiratory, INC | $47.45 | 2020-2021 | |
| Shire North American Group INC | $47.10 | 2019 | |
| Baxter Healthcare | $46.55 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Grifols USA, LLC | $38.59 | 2022-2023 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $35.59 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $34.44 | 2019-2024 | |
| Vifor Pharma, INC. | $22.77 | 2024 | Zemaira |
| Insmed, INC. | $20.40 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $19.98 | 2023 | Dupixent |
| Resmed Corp | $17.57 | 2024 | |
| 3b Medical, INC. | $14.99 | 2024 | Luna |
| Teva Pharmaceuticals USA, INC. | $14.30 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ikemefula Ekekwe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.